PUBLISHER: Grand View Research | PRODUCT CODE: 1630955
PUBLISHER: Grand View Research | PRODUCT CODE: 1630955
The global deep brain stimulation devices market size is anticipated to reach USD 2.50 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 10.2% from 2025 to 2030. Growing awareness about deep brain stimulation therapy, a surge in the incidence of neurological disorders, and the introduction of technologically advanced productsdrive the growth of the market. An increase in FDA approvals for deep brain stimulation devices in clinical applications, such as tremors, severe obsessive-compulsive disorders, and dystonia, is further fueling the market growth. For instance, in December 2022, Nexstim Plc made a notable announcement regarding the sale of two NBT systems. These systems were acquired through Canadian Health Solutions (CHS), the company's distributor in Canada.
This development is expected to have a positive impact on the market's growth in the near future, signaling a growing demand for Nexstim's innovative solutions within the Canadian healthcare landscape. The incidence of neurological disorders such as epilepsy, Parkinson's disease, and depression is increasing globally, which is expected to positively impact the market growth. For instance, as per the Depression and Bipolar Support Alliance, about 17.3 million people in the U.S. are suffering from major depressive disorder. As a result, a large number of people suffering from such conditions & disorders is expected to boost the demand for DBS devices during the forecast period.